Use of selective cytokine inhibitory drugs in myelodysplastic syndromes

Details for Australian Patent Application No. 2004319759 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004319759

PCT Pub. Number WO2005/110085

Filing date 14 April 2004

Wipo publication date 24 November 2005

International Classifications

A61K 31/425 (2006.01) - Thiazoles

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110085 Priority application(s): WO2005/110085

11 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004319761-Pharmaceutical compositions for metabolic insufficiences

2004319758-Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes